Pattern of Use of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation Patients in UK General Practices
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 25 May 2017
At a glance
- Drugs Rivaroxaban (Primary) ; Apixaban; Dabigatran etexilate
- Indications Stroke
- Focus Therapeutic Use
- Sponsors Bayer
- 21 May 2017 Planned End Date changed from 30 May 2017 to 30 Aug 2017.
- 21 May 2017 Planned primary completion date changed from 30 May 2017 to 30 Aug 2017.
- 21 May 2017 Status changed from not yet recruiting to active, no longer recruiting.